Hostname: page-component-84b7d79bbc-c654p Total loading time: 0 Render date: 2024-07-28T02:05:37.363Z Has data issue: false hasContentIssue false
  • English
  • Français

Intradermal cholera vaccination

Published online by Cambridge University Press:  15 May 2009

J. E Noble
J. E Noble
Affiliation:
David Bruce Laboratories, East Everleigh, near Marlborough, Wilts
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The protection afforded by cholera vaccine administered by the intradermal route, and demonstrated by active and passive mouse protection tests, active guinea-pig protection tests, and agglutination titres, is excellent and equal to that given by subcutaneous inoculation.

It is suggested that cholera vaccine administered by the intradermal route would greatly reduce the incidence of reactions which occur when the vaccine is given subcutaneously.

Type
Research Article
Information
Journal of Hygiene , Volume 62 , Issue 1 , March 1964 , pp. 11 - 23
Copyright
Copyright © Cambridge University Press 1964

References

REFERENCES

Barr, M., Sayers, M. H. P. & Stamm, W. P. (1958). Intradermal T.A.B.T. vaccine fo immunization against enteric. Lancet, i, 816.Google Scholar
Burrows, W., Mather, A. N., Elliott, M. E. & Havens, I. (1947). Studies on immunity to Asiatic cholera. III. The mouse protection test. J. infect. Dis. 81, 157.CrossRefGoogle Scholar
Felix, A. & Bensted, H. J. (1954). Proposed standard agglutinating sera for typhoid and paratyphoid A and B fevers. Bull. World Hlth Org. 10, 919.Google ScholarPubMed
Gardner, A. D. & Venkatraman, K. V. (1935). The antigens of the cholera group of vibrios. J. Hyg., Camb., 35, 262.CrossRefGoogle ScholarPubMed
Griffitts, J. J. (1944). Mouse protective antibodies in human serums following injections with cholera vaccine. Publ. Hlth Rep., Wash., 59, 1374.CrossRefGoogle Scholar
Miles, A. A. (1958). The toxicity of intracutaneous TAB vaccine. J. R. Army med. Cps, 104, 89.Google Scholar
Noble, J. E. (1963). Reactions to intradermal TABT and TAB vaccine. J. R. Army med. Cps, 109, 178.Google Scholar
Panja, G. & Das, N. W. (1947). Immunity after intradermal inoculation of cholera vaccine. Indian J. med. Res. 35, 3.Google ScholarPubMed
Pollitzer, R. (1959). Cholera. Wld Hlth Org. Monogr. Ser. no. 43, pp. 222, 236.Google ScholarPubMed
Singer, E., Wei, S. H. & Hoa, S. H. (1948). Cholera immunisation. J. Immunol. 60, 181.CrossRefGoogle Scholar
Vella, E. E. (1963). Cholera vaccines and the El Tor vibrio. Brit. med. J. i, 1203.CrossRefGoogle Scholar
W.H.O. (1959). Requirements for biological substances 4. Cholera vaccine. Tech. Rep. Wld Hlth Org. No. 179, p. 31et seq.Google Scholar